Literature DB >> 15659695

Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU.

Hiromi Sato1, Jimmy B Feix, Cecilia J Hillard, Dara W Frank.   

Abstract

Recombinant ExoU (rExoU) and yeast extract were used to optimize an in vitro phospholipase assay as a basis for identifying the mechanism for enzyme activation and substrate specificity. Our results support a model in which a eukaryotic protein cofactor or complex facilitates the interaction of rExoU with phospholipid substrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659695      PMCID: PMC545705          DOI: 10.1128/JB.187.3.1192-1195.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  21 in total

1.  Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU.

Authors:  Miki Tamura; Temitayo Ajayi; Leonard R Allmond; Kiyoshi Moriyama; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Biochem Biophys Res Commun       Date:  2004-04-02       Impact factor: 3.575

2.  Action of phospholipase A2 on unmodified phosphatidylcholine bilayers: organizational defects are preferred sites of action.

Authors:  G C Upreti; M K Jain
Journal:  J Membr Biol       Date:  1980-07-15       Impact factor: 1.843

3.  Characterization of the lipid acyl hydrolase activity of the major potato (Solanum tuberosum) tuber protein, patatin, by cloning and abundant expression in a baculovirus vector.

Authors:  D L Andrews; B Beames; M D Summers; W D Park
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

4.  Cloning, expression, purification and characterization of patatin, a novel phospholipase A.

Authors:  H J Hirschberg; J W Simons; N Dekker; M R Egmond
Journal:  Eur J Biochem       Date:  2001-10

Review 5.  ExoU is a potent intracellular phospholipase.

Authors:  Hiromi Sato; Dara W Frank
Journal:  Mol Microbiol       Date:  2004-09       Impact factor: 3.501

6.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.

Authors:  J D Clark; L L Lin; R W Kriz; C S Ramesha; L A Sultzman; A Y Lin; N Milona; J L Knopf
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

7.  cPLA2 is phosphorylated and activated by MAP kinase.

Authors:  L L Lin; M Wartmann; A Y Lin; J L Knopf; A Seth; R J Davis
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

8.  Pseudomonas aeruginosa exoenzyme S requires a eukaryotic protein for ADP-ribosyltransferase activity.

Authors:  J Coburn; A V Kane; L Feig; D M Gill
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

9.  Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevisiae.

Authors:  Shira D P Rabin; Alan R Hauser
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Enzymatic hydrolysis of short-chain lecithin/long-chain phospholipid unilamellar vesicles: sensitivity of phospholipases to matrix phase state.

Authors:  N E Gabriel; N V Agman; M F Roberts
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

View more
  32 in total

1.  Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU.

Authors:  Julio C Ramirez; Suzanne M J Fleiszig; Aaron B Sullivan; Connie Tam; Roya Borazjani; David J Evans
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

2.  Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

Authors:  David M Anderson; Katherine M Schmalzer; Hiromi Sato; Monika Casey; Scott S Terhune; Arthur L Haas; Jimmy B Feix; Dara W Frank
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

3.  Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.

Authors:  Jeff L Veesenmeyer; Heather Howell; Andrei S Halavaty; Sebastian Ahrens; Wayne F Anderson; Alan R Hauser
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

4.  MexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosa.

Authors:  Yongxin Jin; Hongjiang Yang; Mingqiang Qiao; Shouguang Jin
Journal:  J Bacteriol       Date:  2010-11-12       Impact factor: 3.490

5.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Vincent T Lee; Stefan Pukatzki; Hiromi Sato; Eriya Kikawada; Anastasia A Kazimirova; Jin Huang; Xiaohua Li; Jonathan P Arm; Dara W Frank; Stephen Lory
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

7.  Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

Authors:  Marc A Benson; Steven M Komas; Katherine M Schmalzer; Monika S Casey; Dara W Frank; Jimmy B Feix
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

9.  PtrB of Pseudomonas aeruginosa suppresses the type III secretion system under the stress of DNA damage.

Authors:  Weihui Wu; Shouguang Jin
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

10.  A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity.

Authors:  Marc A Benson; Katherine M Schmalzer; Dara W Frank
Journal:  Clin Chim Acta       Date:  2009-11-10       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.